News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Mihaela Aldea received a 2024 IASLC YIA
Photo from Mihaela Aldea/X
Jun 28, 2024, 04:59

Mihaela Aldea received a 2024 IASLC YIA

Mihaela Aldea, Medical Oncologist at the Gustave Roussy, shared a post on X:

“Honored to receive a 2024 IASLC YIA (Young Investigator Grants). Congrats to all awardees and friends Biagio Ricciuti, Alessio Cortellini and others.

Collaboration is key to help our patients. Thank you IASLC.”

Read further.
Source: Mihaela Aldea/X

Alessio Cortellini Benjamin Besse Biagio Ricciuti cancer Dana-Farber Gustave Roussy IASLC Mark Awad Mihaela Aldea OncoDaily Oncology YIA Young Investigator Grants
Blog
Jul 2, 2024, 08:27
Symbol of hope and excellence in cancer care - Ethiopian Society of Hematology and Oncology (ESHO)
Blog
Jul 2, 2024, 08:18
Naveen Pemmaraju: Navitoclax and Ruxolitinib in Patients With Untreated Myelofibrosis
Societies
Jul 2, 2024, 07:19
25 Posts You Should Not Miss From ESMOGI24!
Blog
Jul 2, 2024, 05:46
Abdelrahman Ali: Grateful for my time at MD Anderson Cancer Center and the invaluable learning experience
Insight
Jul 2, 2024, 05:35
Benjamin Toll: Strategies to promote gender equality in academia
Insight
Jul 2, 2024, 05:00
AlphaFold’s recent advancements and its potential impact on predictive medicine
Insight
Jul 2, 2024, 04:51
Frequent IgG testing in CLL and NHL showed reduced rates of infections - ASH
Blog
Jul 2, 2024, 04:32
Zhe Huang: Thrilled to be selected for Best Poster for prostate cancer at PrevConf24
Insight
Jul 2, 2024, 04:16
Olivier Calvayrac: TT-derived drug-tolerant (DT) lung cancer cells are vulnerable to FTIs
Blog
Jul 2, 2024, 03:57
Runcie C.W. Chidebe: Tangible progress hinges on addressing the realities faced by LMICs
Blog
Jul 2, 2024, 03:16
C. Jillian Tsai: A very thoughtful opinion piece on caveats of using TTMV-HPV DNA in oropharyngeal carcinoma
Blog
Jul 2, 2024, 03:02
Myriam Chalabi: Patients with stage 1c TNBC with high TILs have an excellent prognosis without chemo